| Dr Witold R Jurewicz, MD | |
|
3021 Jacks Run Rd, White Oak, PA 15131-2523 | |
| (412) 267-5969 | |
| (412) 267-5970 |
| Full Name | Dr Witold R Jurewicz |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 3021 Jacks Run Rd, White Oak, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487670022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD429817 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Passavant | Pittsburgh, PA | Hospital |
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Community Medicine Inc | 2062318975 | 690 |
News Archive
About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that may predict the five-year survival rate of patients suffering from this cancer, now at 16 percent, researchers at Georgia State University and Vanderbilt University Medical Center have concluded.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
The Kansas Health Institute News Service on Monday in a series of articles examined prospects for expanding health coverage in Kansas this year.
› Verified 3 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that may predict the five-year survival rate of patients suffering from this cancer, now at 16 percent, researchers at Georgia State University and Vanderbilt University Medical Center have concluded.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
The Kansas Health Institute News Service on Monday in a series of articles examined prospects for expanding health coverage in Kansas this year.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Witold R Jurewicz, MD 200 Lothrop St, Forbes Tower, Suite 9055, Pittsburgh, PA 15213-2536 Ph: (412) 647-3087 | Dr Witold R Jurewicz, MD 3021 Jacks Run Rd, White Oak, PA 15131-2523 Ph: (412) 267-5969 |
News Archive
About one-third of patients newly diagnosed with the most common form of lung cancer have moderate to severe symptoms of depression, a new study suggests.
Many studies published by major spinal surgery journals do not include full disclosure of researchers' financial conflicts of interest (COIs), reports a study in Spine.
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that may predict the five-year survival rate of patients suffering from this cancer, now at 16 percent, researchers at Georgia State University and Vanderbilt University Medical Center have concluded.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.
The Kansas Health Institute News Service on Monday in a series of articles examined prospects for expanding health coverage in Kansas this year.
› Verified 3 days ago
Dr. Louis A Ditoppa, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1978 Lincoln Way, White Oak, PA 15131 Phone: 412-664-0720 Fax: 412-664-7134 | |
Heather Trautman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Lincoln Way Ste 290, Suite 290, White Oak, PA 15131 Phone: 412-267-5990 | |
Dr. Jan Pomiecko, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1668 Lincoln Way, Second Floor, White Oak, PA 15131 Phone: 412-678-8740 Fax: 478-678-0772 | |
Elisabeth Wang, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Lincoln Way Ste 290, White Oak, PA 15131 Phone: 412-267-5969 | |
Dr. Farial Rawji, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1432 Lincoln Way, Suite 101, White Oak, PA 15131 Phone: 412-672-3633 Fax: 412-672-3810 |